Harbour Trust & Investment Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$436K Hold
3,450
0.04% 116
2026
Q1
$481K Hold
3,450
0.05% 113
2025
Q4
$423K Hold
3,450
0.04% 118
2025
Q3
$383K Hold
3,450
0.04% 124
2025
Q2
$383K Sell
3,450
-20
-0.6% -$2.13K 0.04% 125
2025
Q1
$389K Hold
3,470
0.05% 118
2024
Q4
$321K Hold
3,470
0.04% 130
2024
Q3
$291K Hold
3,470
0.03% 135
2024
Q2
$238K Sell
3,470
-305
-8% -$20.4K 0.03% 147
2024
Q1
$277K Buy
3,775
+305
+9% +$23.5K 0.03% 145
2023
Q4
$281K Buy
+3,470
New +$270K 0.04% 144

Other funds holding GILD

Harbour Trust & Investment Management's GILD Position: Q2 2026 in Review

Harbour Trust & Investment Management held its Gilead Sciences (GILD) position steady in Q2 2026 at 3,450 shares worth $436K. The position accounts for 0.04% of the portfolio, ranked #116.

Harbour Trust & Investment Management first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $481K in Q1 2026. 1,020 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Harbour Trust & Investment Management held 3,450 shares of Gilead Sciences worth $436K as of Q2 2026.
  • Harbour Trust & Investment Management left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.04% of Harbour Trust & Investment Management's portfolio in Q2 2026, its #116 holding.
  • Harbour Trust & Investment Management first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
  • Harbour Trust & Investment Management's Gilead Sciences position peaked at $481K in Q1 2026.
  • 1,020 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Harbour Trust & Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.